[1]CurrentPatentAssignee:SUNESISPHARMACEUTICALSINC-WO2009/114856,2009,A2Locationinpatent:Page/Pagecolumn57-58
[1]CurrentPatentAssignee:SUNESISPHARMACEUTICALSINC-WO2009/114856,2009,A2
[1]CurrentPatentAssignee:SUNESISPHARMACEUTICALSINC-WO2009/114856,2009,A2
[1]CurrentPatentAssignee:SUNESISPHARMACEUTICALSINC-WO2009/114856,2009,A2
[1]CurrentPatentAssignee:SUNESISPHARMACEUTICALSINC-WO2009/114856,2009,A2
Title: Aurora kinase inhibitors as anti-cancer therapy.
Journal: Anti-cancer drugs 20100401
Title: SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo.
Journal: Cancer chemotherapy and pharmacology 20100301
Title: 2-Aminobenzimidazoles as potent Aurora kinase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20090901
Title: Discovery and development of aurora kinase inhibitors as anticancer agents.
Journal: Journal of medicinal chemistry 20090514
Title: The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model.
Journal: Molecular cancer therapeutics 20090401
Title: Water-soluble prodrugs of an Aurora kinase inhibitor.
Journal: Bioorganic & medicinal chemistry letters 20090301
Title: Discovery of a potent and selective aurora kinase inhibitor.
Journal: Bioorganic & medicinal chemistry letters 20080901
Title: Oslob JD, et al. Discovery of a potent and selective aurora kinase inhibitor. Bioorg Med Chem Lett. 2008 Sep 1;18(17):4880-4.
Title: Arbitrario JP, et al. SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo. Cancer Chemother Pharmacol. 2010 Mar;65(4):707-17.
